ALS Research

Approximately 4,000 Canadians are living with amyotrophic lateral sclerosis (ALS) – a devastating neurodegenerative disease affecting nerve cells in the brain and spinal cord, causing loss of muscle control. Some patients may live with ALS for decades, while others decline rapidly. Brain Canada funds cutting-edge research that could support better diagnosis and treatment to improve the lives of people living with ALS.

Learn more

Donate

Our Projects

Brain Canada’s rigorous scientific review process gives donors and partners a trusted mechanism to ensure projects are chosen based on merit, innovation, and potential for impact.

Search the directory

$ 0 invested

0 grants awarded

News

How we are advancing brain health

Read

Inspiring anchor gift from Allan Kliger, Aviva Rajsky and Family to support the inaugural Olivier Goy Rising Star Trainee Award in ALS Research

ALS | Rising Stars | March 25, 2024

Read

Could a ketogenic diet slow the progression of ALS?

ALS | Future Leaders | February 27, 2024

Read

Can we reprogram cells we already have to replace neurons damaged by ALS? This postdoctoral fellow wants to find out

ALS | Brain Canada | October 27, 2023

Our Partners

View all our partners

Making a significant difference in the lives of people in Canada doesn’t happen in a vacuum. It takes a network of visionary partners committed to investing in change. As a national convenor and facilitator, Brain Canada works with partners from coast to coast to drive innovative brain research. Some of our partners in supporting ALS research include:

ALS Society of Canada

Alnylam Pharmaceuticals Inc.

Regeneron Pharmaceuticals Inc.

How you can help

Brain Canada funds the very best Canadian neuroscience, fostering collaborative research and accelerating the pace of discovery, in order to improve the health and quality of life of Canadians who suffer from brain disorders.

Donate

Learn more